Technical Program Manager II
TrueML- Full Time
- Senior (5 to 8 years)
Employment Type: Full-time
Join a world-class team at the forefront of AI and biochemistry. At Genesis Therapeutics, we’re a tight-knit team of proven deep learning researchers, software engineers, and drug discovery pioneers. Our shared mission is nothing short of revolutionary: to forge the next generation of AI foundation models that will unlock groundbreaking therapies for patients with severe diseases.
We don’t just apply machine learning to biology; we are conducting fundamental research at the intersection of machine learning, physics, and computational chemistry, pushing the boundaries of each field. You will work side-by-side with top multidisciplinary researchers to design and build generative foundation models at scale, having access to ample compute and large-scale simulations.
As the Technical Program Manager for our Genesis AI team, you will be the operational leader orchestrating our most critical scientific and engineering initiatives. Your core mission is to drive the end-to-end delivery of our foundation models, ensuring our ambitious research roadmap translates into tangible, high-impact models that power our drug discovery platform.
You will be the nexus of our technical operations, creating the systems and processes that allow our research to scale effectively. You will ensure that our machine learning-led drug discovery programs are delivered on-time, on-scope, and aligned with scientific milestones. You will also help define and mature program processes, experiment governance, and model deployment pipelines that support our scientific mission. This means owning the strategic planning for our large-scale compute resources, implementing rigorous configuration management for reproducible research, and building the connective tissue between our AI researchers, platform engineers, and drug discovery teams.
AI-driven drug discovery for pharmaceuticals
Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to transform the drug discovery process and bring new therapies to market.